“Zero polio transmission and health for all”, WHO Director-General gives new year’s wish to the people of Afghanistan and Pakistan
Update of WHO guidelines on the management of latent TB infection
WHO Director-General concludes New Year visit to Ebola-affected areas in the Democratic Republic of the Congo
WHO Director-General applauds Uganda’s Ebola preparedness response
Statement on disruptions to the Ebola response in the Democratic Republic of the Congo
Nigeria launches Yellow fever vaccination campaign to stop outbreak in Edo state
Global TB Programme - 2018: Year in Review. Looking back to move forward into 2019
WHO updates its treatment guidelines for multidrug- and rifampicin-resistant tuberculosis
GCM/NCD 2018 Highlights – Information, Interaction, Inspiration
Letter to malaria partners (December 2018)
WHO updates guidance to help healthcare workers prevent postpartum haemorrhage
A new multipurpose Infectious Disease Unit opens in Juba, South Sudan
Advancing local production and supply of quality assured medicines to improve access in the Africa region
Implementation research for maternal, newborn and child health interventions
Eliminating financial and economic barriers to tuberculosis diagnosis and care
WHO workshop: visionary plans to scale-up rabies control
WHO data show unprecedented treatment coverage for bilharzia and intestinal worms
Nearly 30 million sick and premature newborns in dire need of treatment every year
Introducing the revamped WHO Civil Society Taskforce: Our close partners in the fight to end TB
Eliminating rabies: potential investment in life-saving vaccines can bolster prospects for zero human rabies deaths
German parliament is committed to global health
Japan strengthens global health security
French Parliament reinforces partnership with WHO
WHO and Wellcome Trust join forces to combat epidemics and drug-resistant infections
WHO and the Principality of Monaco forge new ties to end malaria in Africa’s Sahel region
WHO and EU reinforce cooperation for Universal Health Coverage
First meeting of the IHR Emergency Committee
Second meeting of the IHR Emergency Committee
Third meeting of the IHR Emergency Committee
DG Statement following the meeting of the Emergency Committee
Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo on 17 July 2019
WHO welcomes FDA approval of new formulation of dolutegravir for young children living with HIV
Compulsory drug detention and rehabilitation centres
Countries failing to prevent violence against children, agencies warn
Luxembourg and WHO sign new Memorandum of Understanding, committing flexible funding to support WHO Triple billion targets
United Nations task force on NCDs finds cause for concern and optimism in Belarus
Why we need strong regulatory systems to reach universal health coverage
Tackling the dual burden of TB and diabetes for patients and their families
2nd Anniversary of the WHO Global Ministerial Conference on Ending TB
Bangladesh commits to accelerating the response to end TB
